Meeting
2020 Genitourinary Cancers Symposium
Feasibility and oncologic outcome of salvage surgery in isolated seminal vesical remnants after radical prostatectomy.
Authors
David Pfister
University Hospital of Cologne, Cologne, Germany
David Pfister , Friederike Haidl , Tim Nestler , Pia Paffenholz , Axel Heidenreich
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 137)
Abstract #
137
Poster Bd #
F17
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Risk factors for disease progression after post-prostatectomy salvage radiation: Long-term results of a large institutional experience.
First Author: Danielle Rodin
Poster
2013 Genitourinary Cancers Symposium
Current status and outcomes of salvage radiotherapy for patients with PSA recurrence after prostatectomy: A JROSG surveillance study.
First Author: Takashi Mizowaki
Poster
2023 ASCO Annual Meeting
Primary analysis of STARTAR: A phase 2 salvage trial of androgen receptor (AR) inhibition with androgen deprivation therapy (ADT) and apalutamide with radiation therapy (RT) followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (RP).
First Author: Tian Zhang
Poster
2023 ASCO Genitourinary Cancers Symposium
Phase 2, multicenter, randomized study of salvage radiation therapy +/- metformin for recurrent prostate cancer after radical prostatectomy (SAKK 08/15 – GETUG-AFU 34 PROMET trial).
First Author: Alan Dal Pra